UPDATE 1-EU regulator accepts Sanofi/Regeneron's Dupixent product for review By: Reuters: Company News December 08, 2016 at 01:50 AM EST * Product aimed at treating eczema (Adds detail, background) Read More >> Related Stocks: Banco Santander ADR Regeneron Pharmaceuticals